期刊文献+
共找到118篇文章
< 1 2 6 >
每页显示 20 50 100
Design,delivery and efficacy testing of therapeutic nucleic acids used to inhibit hepatitis C virus gene expression in vitro and in vivo 被引量:9
1
作者 Wolfgang H.Caselmann Matthias Serwe +3 位作者 Thomas Lehmann János Ludwig Brian S.Sproat Joachim W.Engels 《World Journal of Gastroenterology》 SCIE CAS CSCD 2000年第5期626-629,共4页
Despite major achievements in the treatment ofchronic hepatitis C with the combination ofinterferons and the nucleoside analog ribavirin themajority of patients with chronic hepatitis C virus(HCV) infection cannot be ... Despite major achievements in the treatment ofchronic hepatitis C with the combination ofinterferons and the nucleoside analog ribavirin themajority of patients with chronic hepatitis C virus(HCV) infection cannot be treated effectively.Toimprove this response rate we used antisensetechnologies to inhibit HCV translation as possibleadditional option for experimental treatment.Antisense oligodeoxynucleotides(ODN) are 展开更多
关键词 hepatitis C-like viruses/therapy gene expression in VITRO in vivo nucleic acids/therapeutic use CYTOMEGALOVIRUS
下载PDF
Therapeutic and Medicinal Uses of <i>Aloe vera</i>: A Review 被引量:5
2
作者 Pankaj K. Sahu Deen Dayal Giri +5 位作者 Ritu Singh Priyanka Pandey Sharmistha Gupta Atul Kumar Shrivastava Ajay Kumar Kapil Dev Pandey 《Pharmacology & Pharmacy》 2013年第8期599-610,共12页
The plant Aloe vera is used in Ayurvedic, Homoeopathic and Allopathic streams of medicine, and not only tribal community but also most of the people for food and medicine. The plant leaves contains numerous vitamins, ... The plant Aloe vera is used in Ayurvedic, Homoeopathic and Allopathic streams of medicine, and not only tribal community but also most of the people for food and medicine. The plant leaves contains numerous vitamins, minerals, enzymes, amino acids, natural sugars and other bioactive compounds with emollient, purgative, anti-microbial, anti inflammatory, antioxidant, aphrodisiac, anti-helmenthic, antifungal, antiseptic and cosmetic values for health care. This plant has potential to cure sunburns, burns and minor cuts, and even skin cancer. The external use in cosmetic primarily acts as skin healer and prevents injury of epithelial tissues, cures acne and gives a youthful glow to skin, also acts as extremely powerful laxative. 展开更多
关键词 ALOE vera Antimicrobial therapeutic MEDICINAL useS Cosmetic Application
下载PDF
Continuous Wear of Hydrogel Contact Lenses for Therapeutic Use
3
作者 Daisuke Kudo Hiroshi Toshida +1 位作者 Toshihiko Ohta Akira Murakami 《Open Journal of Ophthalmology》 2012年第4期110-113,共4页
Purpose: To investigate the efficacy and complications of continuous wear of etafilcon A for therapeutic use. Materials and Methods: The subjects were 228 eyes of 219 outpatients prescribed contact lens (CL) for one w... Purpose: To investigate the efficacy and complications of continuous wear of etafilcon A for therapeutic use. Materials and Methods: The subjects were 228 eyes of 219 outpatients prescribed contact lens (CL) for one week of continuous therapeutic wear during 10 years. The reason for prescription of CLs, the primary disease, the duration of CL wear and the complications were assessed retrospectively. Results: The predominant reason for prescription of CLs was relief of pain or a foreign-body sensation (62.3%) and protection of the corneal epithelium (20.6%). The primary disease was post-penetrating keratoplasty (36.8%), followed by corneal epithelial erosion (14.5%), post-lamellar keratoplasty (14.0%) and bullous keratopathy (12.2%). The average duration of wearing single lens was 6.5 ± 3.2 days. The average duration of wearing CLs in total was 9.2 ± 10.7 months. The most frequent problem associated with continuous wear of CLs was their dropping out of CLs (12.3%). The complications associated with CLs included conjunctivitis with papillary hyperplasia, corneal erosion and superficial punctate keratitis, but corneal ulcer and corneal infiltrates were not found. Conclusion: Serious complications were not shown changing the lenses every week to keep to the prescribed time limit for continuous therapeutic wear, even if corneal epithelial barrier function is impaired. 展开更多
关键词 therapeutic use BANDAGE Soft Contact LENS CONTINUOUS WEAR COMPLICATION
下载PDF
Comparison of long-lasting therapeutic effects between succimer and penicillamine on hepatolenticular degeneration 被引量:3
4
作者 REN Ming Shan, ZHANG Zhi, WU Jun Xia, LI Fei, XUE Ben Chun and YANG Ren Min 《World Journal of Gastroenterology》 SCIE CAS CSCD 1998年第6期75-77,共3页
AIM To compare the long term effect of succimer (Suc) with that of penicillamine (Pen) in treating hepatolenticular degeneration (HLD). METHODS One hundred and twenty patients with HLD were divided into 2 groups. ... AIM To compare the long term effect of succimer (Suc) with that of penicillamine (Pen) in treating hepatolenticular degeneration (HLD). METHODS One hundred and twenty patients with HLD were divided into 2 groups. Group A ( n =60) received Suc 750mg , po. bid. Group B ( n =60) received Pen 250mg , po. qid. The period of maintenance treatment varied from 6 months to 3 years, averaging 1 5 years. Symptoms and therapeutic effects were evaluated by modified Goldstein scale. RESULTS The total effectiveness of group A in two different periods of treatment were 80% and 85% respectively, higher than those of group B (58% and 59% respectively) ( P <0 05). Suc also had obvious curative effects for the patients who failed in the use of Pen. There were fewer side effect in group A than in group B ( P <0 05). Suc and Pen could increase urinary copper excretion effectively and continually. CONCLUSION Suc is more effective and safer than Pen. Clinically, it can replace Pen as first choice drug for long term maintenance therapy of HLD. 展开更多
关键词 hepatolenticular degeneration/drug THERAPY succimer/therapeutic use penicillamine/therapeutic use
下载PDF
Functional dyspepsia of ulcer-dysmotility type:clinical incidence and therapeutic strategy 被引量:3
5
作者 WANG XiaoZhong and LIN GuZhen 《World Journal of Gastroenterology》 SCIE CAS CSCD 1998年第4期95-96,共2页
Functionaldyspepsiaofulcerdysmotilitytype:clinicalincidenceandtherapeuticstrategyWANGXiaoZhongandLINGuZhe... Functionaldyspepsiaofulcerdysmotilitytype:clinicalincidenceandtherapeuticstrategyWANGXiaoZhongandLINGuZhenSubjectheaadings... 展开更多
关键词 dyspepsia/drug therapy famotidine/therapeutic use cisapride/therapeutic use peptic ULCER gastrointestinal motility
下载PDF
Therapeutic role of template-based lymphadenectomy in urothelial carcinoma of the upper urinary tract 被引量:5
6
作者 Tsunenori Kondo Toshio Takagi Kazunari Tanabe 《World Journal of Clinical Oncology》 CAS 2015年第6期237-251,共15页
Lymphadenectomy for urothelial carcinoma of the upper urinary tract has attracted the attention of physicians. The mapping study of lymphatic spread has shown that a relatively wide area should comprise the regional n... Lymphadenectomy for urothelial carcinoma of the upper urinary tract has attracted the attention of physicians. The mapping study of lymphatic spread has shown that a relatively wide area should comprise the regional nodes for tumors of the right renal pelvis or the right upper two-thirds of the ureter. A prospective study showed that an anatomical templatebased lymphadenectomy significantly improved patient survival in tumors of the renal pelvis. This benefit was more evident for patients with p T2 stage tumors or higher. The risk of regional node recurrence is significant reduced by template-based lymphadenectomy,which is likely to be associated with improved patient survival. The removal of lymph node micrometastases is assumed to be the reason for therapeutic benefit following lymphadenectomy. The number of resected lymph nodes can be used to assess the quality of lymphadenectomy,but not to determine the extent of lymphadenectomy. The guidelines currently recommend lymphadenectomy for patients with muscle-invasive disease,even though the current recommendation grades are still low. The present limitation of lymphadenectomy is the lack of standardization of the extent of lymphadenectomy and the randomized trials. Further studies are warranted to collect the evidence to support lymphadenectomy. 展开更多
关键词 LYMPHADENECTOMY LYMPH node EXCISION UROTHELIAL carcinoma Treatment outcome therapeutic uses Diagnosis GUIDELINE
下载PDF
Blastocystis hominis as a cause of chronic diarrhea in low-resource settings:A systematic review
7
作者 Stephen Amoak Jonathan Soldera 《World Journal of Meta-Analysis》 2024年第3期30-41,共12页
BACKGROUND Blastocystis hominis(B.hominis),an anaerobic unicellular protist parasite,is known for its diverse clinical manifestations upon infecting the human gastrointestinal tract.Although globally distributed,it is... BACKGROUND Blastocystis hominis(B.hominis),an anaerobic unicellular protist parasite,is known for its diverse clinical manifestations upon infecting the human gastrointestinal tract.Although globally distributed,it is particularly prevalent in developing nations.Examining the symptoms and treatment outcomes of B.hominis infection in low-resource settings holds immense significance,providing healthcare practi-tioners with valuable insights to enhance patient care.AIM To synthesize existing evidence on the symptomatology and treatment outcomes of B.hominis infection in low-resource settings.METHODS Following the Preferred Reporting Items for Systematic Review and Meta-Analysis guidelines,a systematic review was conducted.The search spanned electronic databases including PubMed,Scopus,and Google Scholar.After a comprehensive screening process,a thorough examination of the papers,adhering to inclusion and exclusion criteria,and data extraction from eligible studies was conducted.The findings underwent summarization through simple descriptive analysis.RESULTS The search yielded 1200 papers,with 17 meeting inclusion criteria.Chronic diarrhea due to B.hominis infection was reported in only two studies,while abdominal pain,diarrhea,flatulence,constipation,and nausea/vomiting emerged as the most commonly documented symptoms.Recovery rates after one week of treatment ranged from 71.8%to 100%,and after two weeks,from 60%to 100%.CONCLUSION In low-resource settings,chronic diarrhea resulting from B.hominis infection is infrequent.Common symptoms include abdominal pain,diarrhea,flatulence,constipation,and nausea/vomiting.Post-treatment,clinical outcomes are notably favorable,supporting the recommendation for treatment.Metronidazole is advocated as the first-line agent,with consideration for switching to a second-line option in cases of treatment failure or poor response. 展开更多
关键词 Blastocystis infections Gastrointestinal diseases Treatment outcome Developing countries Metronidazole/therapeutic use
下载PDF
Clinacanthus nutans:a review of the medicinal uses,pharmacology and phytochemistry 被引量:10
8
作者 Md.Ariful Alam Sahena Ferdosh +4 位作者 Kashif Ghafoor Md.Abdul Hakim Abdul Shukor Juraimi Alfi Khatib Md.Zaidul I.Sarker 《Asian Pacific Journal of Tropical Medicine》 SCIE CAS 2016年第4期393-399,共7页
Clinacanthus nutans Lindau is known as snake grass belonging to the Acanlhaceae family.This plant has diverse and potential medicinal uses in traditional herbal medicine for treating skin rashes,insects and snake bite... Clinacanthus nutans Lindau is known as snake grass belonging to the Acanlhaceae family.This plant has diverse and potential medicinal uses in traditional herbal medicine for treating skin rashes,insects and snake bites,lesions caused by herpes simplex virus,diabetes,and gout in Malaysia.Indonesia.Thailand and China.Phylochemieal investigations documented the varied contents of bioaclive compounds from litis plant namely flavonoids,glycosides,glycoglyeerolipids.cerebrosides and monoacylmonogalatosylglycerol.The pharmacological experiment proved that various types of extracts and pure compounds from this species exhibited a broad range of biological properties such as anti-inflammatory,antiviral,antioxidant,and anti-diabetic activities.The lindings of toxicity study showed that extracts from this plant did not show any toxicity thus it can be used as strong therapeutic agents for specific diseased conditions.However,further experiments on chemical components and their mode of action showing biological activities are required to elucidate the complete phytochemical profile and assess to confirm their suitability tor future drugs.This review summarizes the medicinal uses,phytochemistry and pharmacology of this plant in order to explore its therapeutic potential and gaps necessitating for prospected research work. 展开更多
关键词 Clinacanthus nutans MEDICINAL useS PHYTOCHEMICALS PHARMACOLOGY therapeutic potential
下载PDF
High-intensity focused ultrasound extracorporeal ablation of liver tissuesin rabbits
9
《World Journal of Gastroenterology》 SCIE CAS CSCD 1998年第2期16-16,共1页
HighintensityfocusedultrasoundextracorporealablationoflivertissuesinrabbitsCHENGShuQun1,ZHOUXinDa1,TANGZ... HighintensityfocusedultrasoundextracorporealablationoflivertissuesinrabbitsCHENGShuQun1,ZHOUXinDa1,TANGZhaoYou1,YUYao1,B... 展开更多
关键词 LIVER neoplasms experimental/therapy ultrasonic THERAPY iodized oil/therapeutic use liver/radiation effects randomized controlled trials
下载PDF
聚普瑞锌联合奥美拉唑治疗消化性溃疡导致的上消化道出血的临床价值研究 被引量:1
10
作者 郭少勇 《系统医学》 2024年第11期80-83,共4页
目的 分析聚普瑞锌颗粒联合奥美拉唑对消化性溃疡导致的上消化道出血患者治疗效果和不良反应的影响。方法 选取2017年1月—2023年11月阜宁县人民医院消化内科收治的60例消化性溃疡导致上消化道出血患者为研究对象,采用信封法分为两组,每... 目的 分析聚普瑞锌颗粒联合奥美拉唑对消化性溃疡导致的上消化道出血患者治疗效果和不良反应的影响。方法 选取2017年1月—2023年11月阜宁县人民医院消化内科收治的60例消化性溃疡导致上消化道出血患者为研究对象,采用信封法分为两组,每组30例。对照组单纯采用奥美拉唑治疗,观察组在对照组基础上联合使用聚普瑞锌颗粒治疗。对比两组临床疗效、不良反应、症状积分。结果 观察组治疗总有效率(96.67%)高于对照组(73.33%),差异有统计学意义(χ^(2)=4.706,P<0.05)。观察组不良反应发生率(6.67%)低于对照组(26.67%),差异有统计学意义(χ^(2)=4.320,P<0.05)。观察组腹胀、腹痛、恶心呕吐症状积分均低于对照组,差异有统计学意义(P均<0.05)。结论 聚普瑞锌+奥美拉唑联合用于消化性溃疡导致的上消化道出血患者治疗中,具有理想治疗作用,可以改善患者症状和预后状态,减少不良反应的发生。 展开更多
关键词 聚普瑞锌颗粒 奥美拉唑 消化性溃疡 上消化道出血 治疗效果 不良反应 症状积分
下载PDF
Controversies regarding transplantation of mesenchymal stem cells
11
作者 Tsvetelina Velikova Tereza Dekova Dimitrina Georgieva Miteva 《World Journal of Transplantation》 2024年第2期48-61,共14页
Mesenchymal stem cells(MSCs)have tantalized regenerative medicine with their therapeutic potential,yet a cloud of controversies looms over their clinical tran-splantation.This comprehensive review navigates the intric... Mesenchymal stem cells(MSCs)have tantalized regenerative medicine with their therapeutic potential,yet a cloud of controversies looms over their clinical tran-splantation.This comprehensive review navigates the intricate landscape of MSC controversies,drawing upon 15 years of clinical experience and research.We delve into the fundamental properties of MSCs,exploring their unique immuno-modulatory capabilities and surface markers.The heart of our inquiry lies in the controversial applications of MSC transplantation,including the perennial debate between autologous and allogeneic sources,concerns about efficacy,and lingering safety apprehensions.Moreover,we unravel the enigmatic mechanisms surro-unding MSC transplantation,such as homing,integration,and the delicate balance between differentiation and paracrine effects.We also assess the current status of clinical trials and the ever-evolving regulatory landscape.As we peer into the future,we examine emerging trends,envisioning personalized medicine and innovative delivery methods.Our review provides a balanced and informed perspective on the controversies,offering readers a clear understanding of the complexities,challenges,and potential solutions in MSC transplantation. 展开更多
关键词 Mesenchymal stem cells Transplantation controversies Regenerative medicine Autoimmune diseases Chronic inflammatory illnesses Tumor growth METASTASIS therapeutic potential Clinical use of mesenchymal stem cell
下载PDF
多潘立酮联合奥美拉唑对功能性消化不良患者的疗效观察
12
作者 高丹丹 赵亚青 +3 位作者 陈俊 潘孝举 刘欣 李行伟 《临床研究》 2024年第2期76-78,共3页
目的探讨功能性消化不良(FD)患者采用多潘立酮联合奥美拉唑治疗的应用效果。方法选取2021年5月至2022年4月杞县人民医院收治的共计104例FD患者,按照随机数字表法分成研究组(n=52)与对照组(n=52),对照组采用奥美拉唑治疗,研究组采用多潘... 目的探讨功能性消化不良(FD)患者采用多潘立酮联合奥美拉唑治疗的应用效果。方法选取2021年5月至2022年4月杞县人民医院收治的共计104例FD患者,按照随机数字表法分成研究组(n=52)与对照组(n=52),对照组采用奥美拉唑治疗,研究组采用多潘立酮联合奥美拉唑治疗,对两组临床疗效、临床症状评分、胃肠激素水平及不良反应进行比较。结果研究组治疗有效率高于对照组,差异有统计学意义(P<0.05);治疗后两组临床症状(上腹痛、餐后饱腹、上腹部灼烧感)评分降低,且研究组低于对照组,差异有统计学意义(P<0.05);治疗后两组胃动素(MOT)、促胃泌素(GAS)水平升高,生长抑素(SS)水平降低,且研究组MOT、GAS水平更高,SS更低,差异有统计学意义(P<0.05);研究组不良反应发生率低于对照组,差异有统计学意义(P<0.05)。结论多潘立酮联合奥美拉唑应用于FD患者治疗中,可提高临床疗效,缓解临床症状,改善胃肠激素水平,减少不良反应发生。 展开更多
关键词 多潘立酮 奥美拉唑 功能性消化不良 疗效
下载PDF
奥美拉唑、雷贝拉唑和埃索美拉唑三种质子泵抑制剂在反流性食管炎治疗中的效果分析与探究
13
作者 谭海成 焦云涛 张立宏 《中外医疗》 2024年第13期1-4,共4页
目的探讨奥美拉唑、雷贝拉唑和埃索美拉唑三种质子泵抑制剂在反流性食管炎治疗中的效果。方法方便选取2020年6月—2023年6月北京中医医院顺义医院收治的102例反流性食管炎患者为研究对象,按随机数表法分为3组,A组(n=34)应用奥美拉唑,B组... 目的探讨奥美拉唑、雷贝拉唑和埃索美拉唑三种质子泵抑制剂在反流性食管炎治疗中的效果。方法方便选取2020年6月—2023年6月北京中医医院顺义医院收治的102例反流性食管炎患者为研究对象,按随机数表法分为3组,A组(n=34)应用奥美拉唑,B组(n=34)应用雷贝拉唑,C组(n=34)应用埃索美拉唑,对3组临床疗效进行对比。结果C组有效率(97.06%)比A组(85.29%)、B组(88.23%)高,差异有统计学意义(χ^(2)=5.758,P<0.05),而A组、B组有效率对比,差异无统计学意义(P>0.05);A、B两组不良反应发生率对比,差异无统计学意义(P>0.05),和A组、B组相比,C组不良反应发生率更低,差异有统计学意义(P<0.05);且C组治疗后胃灼热、反流、胸骨后灼痛积分比A组、B组低,差异有统计学意义(P均<0.05)。结论埃索美拉唑应用于反流性食管炎中的效果更佳,实际中可以依据患者的病情和经济情况合理选择药物治疗。 展开更多
关键词 奥美拉唑 雷贝拉唑 埃索美拉唑 质子泵抑制剂 反流性食管炎 治疗效果
下载PDF
奥美拉唑三联疗法与四联疗法治疗Hp阳性胃炎的临床效果
14
作者 李秋 《反射疗法与康复医学》 2024年第7期58-61,共4页
目的探讨奥美拉唑三联与四联疗法治疗幽门螺杆菌(Hp)阳性胃炎的临床效果。方法选择2021年5月—2023年5月巨野县中医医院收治的120例Hp阳性胃炎患者为研究对象,以随机数表法分为对照组和观察组,每组60例。对照组采用奥美拉唑三联疗法治疗... 目的探讨奥美拉唑三联与四联疗法治疗幽门螺杆菌(Hp)阳性胃炎的临床效果。方法选择2021年5月—2023年5月巨野县中医医院收治的120例Hp阳性胃炎患者为研究对象,以随机数表法分为对照组和观察组,每组60例。对照组采用奥美拉唑三联疗法治疗,观察组采用奥美拉唑四联疗法治疗。比较两组患者的疗效、血清炎症因子水平、胃泌素族指标水平及不良反应发生情况。结果观察组的治疗总有效率为96.67%,高于对照组的83.33%,差异有统计学意义(P<0.05)。治疗后,观察组的C反应蛋白、降钙素原、肿瘤坏死因子-α、白细胞介素-6水平均低于对照组,组间差异有统计学意义(P<0.05)。治疗后,观察组的胆囊收缩素、胃泌素水平均低于对照组,胃动素、胃泌素17水平均高于对照组,组间差异有统计学意义(P<0.05)。两组的不良反应发生率比较,差异无统计学意义(P>0.05)。结论采用奥美拉唑四联疗法治疗Hp阳性胃炎的效果更理想,安全性更高。 展开更多
关键词 胃炎 幽门螺杆菌阳性 奥美拉唑 三联疗法 四联疗法 治疗效果 不良反应
下载PDF
USE OF CELL-BASED BIOASSAY FOR THE QUALITY CONTROL OF BOTANICAL THERAPEUTICS
15
作者 Doo Suk Lee Min-Jung Bae Sunyoung Kim 《World Journal of Traditional Chinese Medicine》 2015年第4期91-91,共1页
The single most important factor in modernization efforts of traditional oriental medicines is the limited understanding of active compounds responsible for claimed therapeutic effects.Indeed,the unknown identity of b... The single most important factor in modernization efforts of traditional oriental medicines is the limited understanding of active compounds responsible for claimed therapeutic effects.Indeed,the unknown identity of biologically active molecules generates major difficulties associated with botanical therapeutics in general.This includes management of raw materials,poor understanding of 展开更多
关键词 use OF CELL-BASED BIOASSAY FOR THE QUALITY CONTROL OF BOTANICAL therapeuticS PG
原文传递
奥曲肽联合奥美拉唑治疗肝硬化上消化道出血的疗效观察 被引量:85
16
作者 宋奇峰 周建波 +1 位作者 桑建忠 孙晓晖 《中国生化药物杂志》 CAS 2016年第8期127-129,共3页
目的观察并研究奥曲肽联合奥美拉唑治疗肝硬化上消化道出血患者的临床疗效。方法选取2013年1月~2014年12月期间在余姚市人民医院消化内科收治的76例肝硬化上消化道出血患者随机分成观察组和对照组,每组各38例,在实验前均对2组患者均进... 目的观察并研究奥曲肽联合奥美拉唑治疗肝硬化上消化道出血患者的临床疗效。方法选取2013年1月~2014年12月期间在余姚市人民医院消化内科收治的76例肝硬化上消化道出血患者随机分成观察组和对照组,每组各38例,在实验前均对2组患者均进行基础的对症治疗。对照组患者给予奥曲肽治疗,首次给药将0.1 mg奥曲肽溶于20 m L 0.9%Na Cl溶液后静脉推注,之后以25μg/h持续静脉滴注,维持72 h。观察组在对照组的基础上,将奥美拉唑40 mg溶于100 m L 0.9%Na Cl溶液,进行静脉滴注,2次/天,持续治疗3 d。分别观察2组患者的疗效、止血时间、输血量,以及治疗过程中患者的再出血和不良反应发生率。结果观察组总有效率89.47%显著高于对照组63.16%(P〈0.05),观察组的显效率55.26%显著高于对照组31.58%(P〈0.05);观察组的止血时间和输血量均显著小于对照组,且各项差异均具有统计学意义(P〈0.05);此外,观察组的再出血发生率5.26%显著小于对照组21.05%(P〈0.05);治疗过程中观察组和对照组中患者的不良反应发生率分别为10.53%和7.89%,两者差异无统计学意义。结论奥曲肽联合奥美拉唑治疗肝硬化上消化道出血,有利于缩短止血时间,减少输血量,减小再出血风险,能显著改善临床疗效。 展开更多
关键词 奥曲肽 奥美拉唑 肝硬化 上消化道出血 临床疗效
下载PDF
阿托品联合奥美拉唑治疗急性胃炎的疗效及对炎症因子的影响 被引量:9
17
作者 白蓉蓉 龙涛 +1 位作者 李智 黄磊 《世界华人消化杂志》 CAS 2016年第34期4596-4599,共4页
目的研究阿托品联合奥美拉唑在急性胃炎患者中的临床治疗效果及对炎症因子的影响.方法选取2015-04/2016-07医院诊治的急性胃炎患者100例,根据治疗方案不同随机分为对照组(n=50)和观察组(n=50).对照组采用山莨菪碱联合奥美拉唑治疗,观察... 目的研究阿托品联合奥美拉唑在急性胃炎患者中的临床治疗效果及对炎症因子的影响.方法选取2015-04/2016-07医院诊治的急性胃炎患者100例,根据治疗方案不同随机分为对照组(n=50)和观察组(n=50).对照组采用山莨菪碱联合奥美拉唑治疗,观察组采用阿托品联合奥美拉唑治疗,比较两组临床疗效及对炎症因子的影响.结果观察组治疗后临床症状,如:恶心呕吐、上腹剧痛、腹泻及住院时间,显著短于对照组(P<0.05);观察组治疗后炎症因子干扰素-β、肿瘤坏死因子-α及白介素-6水平,显著低于对照组(P<0.05).观察组治疗后药物不良反应发生率显著低于对照组(6.00%vs 16.00%,P<0.05).结论急性胃炎患者采用阿托品联合奥美拉唑治疗效果理想,能抑制炎症反应,改善患者症状. 展开更多
关键词 阿托品 奥美拉唑 急性胃炎 治疗效果 炎症因子
下载PDF
奥美拉唑治疗非静脉曲张性上消化道出血的疗效观察 被引量:9
18
作者 乔进朋 鲁力锋 +2 位作者 王晓燕 张莉 王艳 《中国医院用药评价与分析》 2009年第4期311-312,共2页
目的:观察奥美拉唑治疗非静脉曲张性上消化道出血的疗效。方法:将246例非静脉曲张性上消化道出血患者作为研究对象,随机分为3组,分别为奥美拉唑静脉滴注组、奥美拉唑80 mg泵入组、奥美拉唑160 mg泵入组,各组患者数均为82例,然后比较各... 目的:观察奥美拉唑治疗非静脉曲张性上消化道出血的疗效。方法:将246例非静脉曲张性上消化道出血患者作为研究对象,随机分为3组,分别为奥美拉唑静脉滴注组、奥美拉唑80 mg泵入组、奥美拉唑160 mg泵入组,各组患者数均为82例,然后比较各组治疗方法的临床疗效。结果:不同给药治疗方法疗效有显著性差别(P<0.05)。结论:奥美拉唑持续静脉泵入治疗非静脉曲张性上消化道出血效果好于奥美拉唑分次静脉滴注,且大剂量奥美拉唑持续泵入治疗能够达到更好的止血效果。 展开更多
关键词 奥美拉唑 非静脉曲张性上消化道出血 疗效
下载PDF
以奥美拉唑为主的三联疗法治疗小儿消化性溃疡60例 被引量:39
19
作者 吕茵 李治昌 《陕西医学杂志》 CAS 2013年第9期1125-1127,共3页
目的:探讨以奥美拉唑为主的三联疗法治疗小儿消化性溃疡的临床疗效。方法:选择120例消化性溃疡的患儿,按不同治疗方法分为观察组与对照组,每组60例。观察组采用奥美拉唑+阿莫西林+克拉霉素三联疗法,对照组采用雷尼替丁+阿莫西林+克拉霉... 目的:探讨以奥美拉唑为主的三联疗法治疗小儿消化性溃疡的临床疗效。方法:选择120例消化性溃疡的患儿,按不同治疗方法分为观察组与对照组,每组60例。观察组采用奥美拉唑+阿莫西林+克拉霉素三联疗法,对照组采用雷尼替丁+阿莫西林+克拉霉素三联疗法,比较两组患儿治疗1个月后的临床效果。结果:观察组患儿愈合率及总有效率分别达88.3%及98.3%,明显较对照组高(P<0.05)。观察组HP根除率为91.6%,明显较对照组(63.3%)高(P<0.05),而观察组复发率为3.3%,较对照组(8.3%)低(P<0.05)。两组患儿用药后不良反应无显著性差异(P>0.05)。结论:以奥美拉唑为主的三联疗法治疗小儿消化性溃疡安全有效,HP根除明显,治愈率高,复发率低,可作为小儿消化性溃疡的首选治疗方案。 展开更多
关键词 消化性溃疡 药物疗法 奥美拉唑 治疗应用 阿莫西林 治疗应用 雷尼替丁 治疗应用 对比研究 儿童
下载PDF
环孢素血药浓度异常患者的处置及分析 被引量:4
20
作者 孙浩 杨振宇 肇丽梅 《医药导报》 CAS 北大核心 2021年第8期1120-1123,共4页
目的临床药师通过参与个体化药物治疗,为临床应用环孢素提供参考。方法以1例异基因造血干细胞移植术后,长期应用环孢素抗排异治疗患者为研究对象。该患者环孢素治疗期间,联用奥美拉唑、伏立康唑,出现环孢素血药浓度的异常波动,潜在影响... 目的临床药师通过参与个体化药物治疗,为临床应用环孢素提供参考。方法以1例异基因造血干细胞移植术后,长期应用环孢素抗排异治疗患者为研究对象。该患者环孢素治疗期间,联用奥美拉唑、伏立康唑,出现环孢素血药浓度的异常波动,潜在影响患者用药有效性的同时,该患者出现心律失常、肝肾功能指标异常等一系列不良反应。结果通过分析环孢素血药浓度影响因素,配合血药浓度监测,临床药师优化了环孢素的给药剂量,实现了个体化用药。结论应慎重选用可与环孢素代谢酶存在相互作用的药物,并制定个体化给药方案,以保证患者用药安全有效。 展开更多
关键词 环孢素 治疗药物监测 奥美拉唑 伏立康唑 药物相互作用
下载PDF
上一页 1 2 6 下一页 到第
使用帮助 返回顶部